Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma.
about
Fundamentals of cancer metabolismCerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target EngagementIdentifying new small molecule anti-invasive compounds for glioma treatmentGetting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrierOxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticlesQuantitative Analysis of the Cellular Microenvironment of Glioblastoma to Develop Predictive Statistical Models of Overall Survival.Interstitial flow differentially increases patient-derived glioblastoma stem cell invasion via CXCR4, CXCL12, and CD44-mediated mechanisms.Current approaches to the treatment of metastatic brain tumours.NADPH oxidase 4 induces cardiac arrhythmic phenotype in zebrafishGentian violet: a 19th century drug re-emerges in the 21st centuryA cell-based fascin bioassay identifies compounds with potential anti-metastasis or cognition-enhancing functions.PHIPing out: a genetic basis for tumor ulceration.VEGF-B promotes cancer metastasis through a VEGF-A-independent mechanism and serves as a marker of poor prognosis for cancer patientsRedox-modulating agents target NOX2-dependent IKKε oncogenic kinase expression and proliferation in human breast cancer cell linesDiscovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor.VEGF-B-Neuropilin-1 signaling is spatiotemporally indispensable for vascular and neuronal development in zebrafish.Unique biology of gliomas: challenges and opportunities.Effects of iodonium-class flavin dehydrogenase inhibitors on growth, reactive oxygen production, cell cycle progression, NADPH oxidase 1 levels, and gene expression in human colon cancer cells and xenografts.Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization.The Src homology 3 domain-containing guanine nucleotide exchange factor is overexpressed in high-grade gliomas and promotes tumor necrosis factor-like weak inducer of apoptosis-fibroblast growth factor-inducible 14-induced cell migration and invasioInhibition of FoxM1-Mediated DNA Repair by Imipramine Blue Suppresses Breast Cancer Growth and MetastasisVascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth.High-efficiency liposomal encapsulation of a tyrosine kinase inhibitor leads to improved in vivo toxicity and tumor response profile.Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia.Implications of Rho GTPase Signaling in Glioma Cell Invasion and Tumor Progression.Toxicity of imine-iminium dyes and pigments: electron transfer, radicals, oxidative stress and other physiological effects.The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer.Mitochondrial reactive oxygen species and cancer.Glioma Cell Invasion is Significantly Enhanced in Composite Hydrogel Matrices Composed of Chondroitin 4- and 4,6-Sulfated GlycosaminoglycansSGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to TemozolomideImipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation.Renal Carcinogenesis, Tumor Heterogeneity, and Reactive Oxygen Species: Tactics Evolved.The impact of hypoxia in pancreatic cancer invasion and metastasis.Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cellsAssay to visualize specific protein oxidation reveals spatio-temporal regulation of SHP2.NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cells.Regression of diffuse B-cell lymphoma of the leg with intralesional gentian violet.Glioblastoma on a microfluidic chip: Generating pseudopalisades and enhancing aggressiveness through blood vessel obstruction events.Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections.
P2860
Q26744062-96516B24-3278-4F47-864C-8629EDCD8B69Q26751153-D1926481-1754-4C10-909F-3C7B2A5292A1Q26861119-0A8100D0-61D8-44FA-8981-2556D677FD4CQ27025151-52BC09A9-200F-4E50-A9F9-60FB3F0C80EDQ28071873-2ED9EB10-F43B-41A7-A53D-B2C0478D3F82Q28075551-70E65A2D-6C11-44C7-8F2A-ED9B754E59A5Q30275479-5E933F14-668A-4389-98E8-4075849230ADQ30275623-2BD8717F-79C1-4494-BA2C-7D9579F7D899Q33696559-CD99643A-CF50-4BB8-9884-C090BC2A9ADAQ34044788-FFAE5470-F10C-47EE-B8F7-268F60B8361BQ34377198-CDD9245B-DD9E-445B-9901-29016FF4CE9EQ34392217-5E54C0D1-BA6C-488A-B9E5-61AE3A0D8D6AQ35546486-93176FC4-91E8-4D00-AD08-E96FD263579FQ35698934-7DE5B5B5-5554-4819-9AD5-1F2B4AC2F06CQ35880182-5CC0D9D9-33C4-4AC3-8536-EAEDF4BC5E25Q35984159-2B5EE919-1941-4DEC-AAC6-8B8BC0D20199Q36268590-9D15CB30-5996-45C7-9E7C-0E7068538482Q36626214-716661C8-EE4A-40EB-AC6D-A1437D402838Q36674761-96DCF315-65DF-40C0-B32A-A46355F47A21Q36700252-438BFF88-CDEA-45CD-85DE-BB502CAB214DQ37048438-E10997B1-3FE2-4581-BE06-8F02FBD14EE5Q37100069-C88055D3-795B-41CF-8E05-19BE2EAAFB6AQ37117805-A95463A8-B8B2-47EA-B63E-65627E340A46Q37255085-1EA3D9CF-04C4-447F-94A7-1DD0FDF88980Q37588345-BEC54667-EF37-4761-86D6-768A6C4EA039Q38151113-34A8567A-F9FB-46D7-A797-99C84F326D5DQ38213893-BF5D5DAB-4F11-40A6-943B-331DA3CB3DDFQ38261369-AE7BBEA8-34D8-40AA-AFB0-62E8C0A84468Q38351698-606A00A6-5E87-4446-B1A5-A8BC2158DA6CQ38715700-D4B5317F-34DB-4761-991F-9CAE11116D1FQ38803824-99B90780-9A9B-4802-A13F-65DCD247BEBFQ38845014-6BC31C70-89FF-4559-9784-F75C171436EFQ38854862-FC0949AD-5A40-4B86-922C-5F275D1074E0Q38989132-153B4CE9-6A0C-48B3-B948-31B084566AF3Q40985734-DBC67CDC-E217-473B-B285-2234D255054AQ41631060-985F6792-3951-4062-AEB6-AF3A9B31066DQ46679237-9F5F03B7-ADC4-4784-B8BB-921A90C03F17Q47790294-905D0F90-0C22-43A6-AC80-BF189E143024Q48003634-4B95EC5C-3887-4CB7-8714-BAAA6F6CBB3EQ48163093-DA8851EE-BA79-49A8-9E1A-09BE1A716585
P2860
Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Anti-invasive adjuvant therapy ...... eutic efficacy against glioma.
@en
Anti-invasive adjuvant therapy ...... eutic efficacy against glioma.
@nl
type
label
Anti-invasive adjuvant therapy ...... eutic efficacy against glioma.
@en
Anti-invasive adjuvant therapy ...... eutic efficacy against glioma.
@nl
prefLabel
Anti-invasive adjuvant therapy ...... eutic efficacy against glioma.
@en
Anti-invasive adjuvant therapy ...... eutic efficacy against glioma.
@nl
P2093
P2860
P50
P1476
Anti-invasive adjuvant therapy ...... eutic efficacy against glioma.
@en
P2093
Daniel J Brat
Jack L Arbiser
Levi Fried
Michael Y Bonner
Ravi V Bellamkonda
Sara A Courtneidge
Sydney A Rowson
P2860
P304
P356
10.1126/SCITRANSLMED.3003016
P407
P577
2012-03-01T00:00:00Z